Machine learning-based prediction of ICU admission and mortality in Crimean-Congo hemorrhagic fever by using

Ahu Cephe1, Seyit Ali Büyüktuna2, Necla Koçhan3

  • 1Institutional Data Management and Analytics Coordination Unit, Erciyes University, Kayseri, Türkiye.

Insights

Amino-acid profiles accurately predict Crimean-Congo Hemorrhagic Fever (CCHF) progression using machine learning. Specific amino acids like arginine and glutamic acid are key biomarkers for identifying high-risk patients and improving survival predictions.

Area of Science:

  • Biochemistry
  • Medical Informatics
  • Infectious Diseases

Background:

  • Crimean-Congo Hemorrhagic Fever (CCHF) is a severe viral illness with high mortality.
  • Predicting disease progression and patient outcomes in CCHF remains challenging.
  • Identifying reliable biomarkers is crucial for effective patient management and risk stratification.

Purpose of the Study:

  • To evaluate the predictive power of amino-acid profiles for CCHF disease progression.
  • To identify specific amino acids associated with clinical outcomes and survival in CCHF patients.
  • To leverage machine learning (ML) for early risk stratification in CCHF.

Main Methods:

  • Utilized amino acid profiles (32 concentrations) from 115 confirmed CCHF patients as input for ML models.
  • Employed classification models (XGBOOST, LASSO) to predict intensive care unit (ICU) admission.
  • Applied survival analysis models (Survival LASSO, RFSRC, Survival XGBOOST) to assess patient survival.

Main Results:

  • XGBOOST and LASSO achieved high accuracy (AUC 0.958) in predicting ICU admission.
  • Arginine and glutamic acid were the most significant predictors of ICU admission across models.
  • Survival models demonstrated strong predictive performance, with ornithine, gamma-aminobutyric acid, and arginine being key amino acids for survival prediction.

Conclusions:

  • ML models utilizing amino-acid profiles can accurately predict CCHF disease progression.
  • Amino acid profiles offer valuable insights into the metabolic underpinnings of CCHF severity.
  • This approach supports early risk stratification and personalized treatment strategies for CCHF patients.
Abstract

Related Concept Videos